A phase I, first-in-human study reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising as a potential therapy for RET-driven cancers, such as medullary and papillary thyroid, non-small cell lung, colorectal and bile duct cancers, which have been historically difficult to treat.
Free In-Person Chronic Fatigue Evaluation
Search for any Health Related Issue
Silent KIller: Inflamation
Inflammation: The Often Unknown Factor Inflammation can’t really be seen or felt, yet it may be hurting some part of your body right now 173  0 Inflammation
Inflammation: The Often Unknown Factor Inflammation can’t really be seen or felt, ..
- Possible Miracles Of Exosomes Extracellular vesicles have emerged as important mediators of intercellular communication, and have gained interest for therapeutic potential 125 0
- Paralyzed mice with spinal cord injury made to walk again
- Link Between DNA Methylation And Non-Alcoholic Fatty Liver Disease
- Scientists Have ID Genesis Of Alzheimer’s Disease
- Yeast species used in food industry can cause disease in humans, study finds
Broken bones among older people increase their risk of death for up to 10 years, acc..